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Edited by Mark StittAbstract Plant legumains are cysteine proteinases putatively
involved in processing endogenous proteins. Phytocystatins (Phy-
Cys) have been described as plant inhibitors of papain-like cys-
teine proteinases. Some PhyCys contain a carboxy terminal
extension with an amino acid motif (SNSL) similar to that in-
volved in the inhibition of legumain-like proteins by human cyst-
atins. The role of these carboxy terminal extended PhyCys as
inhibitors of legumain-like cysteine proteinases is here shown
by in vitro inhibition of human legumain and legumain-like activ-
ities from barley extracts. Moreover, site-directed mutagenesis
has demonstrated that the asparagine of the SNSL motif is
essential in this inhibition. We prove for ﬁrst time the existence
of legumain inhibitors in plants.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Legumains are a family of Asn-speciﬁc cysteine proteinases
(family C13; MEROPS peptidase database, http:merops.san-
ger.ac.uk) that have been described in animals and plants
[1,2]. In plants, there is abundant evidence that legumains per-
form a protein-processing function that causes a limited prote-
olysis of precursor proteins [3]. In spite of their important role,
it has not been reported any legumain-like inhibitor from
plants.
Cystatins are proteinaceous inhibitors of papain-like cys-
teine proteinases (family C1A). Several animal cystatins also
inhibit cysteine proteinases of the legumain-related family.
Phytocystatins (PhyCys) are speciﬁc inhibitors from plants
that share with animal cystatins the three motifs involved in
the interaction with papain-like enzymes: the reactive site
QxVxG, one or two glycine residues in the N-terminal part
of the protein and a tryptophan located down-stream of the
reactive site. In addition, PhyCys have a consensus sequence
([LVI]-[AGT]-[RKE]-[FY]-[AS]-[VI]-x-[EDQV]-[HYFQ]-N) that
conforms to a predicted secondary a-helix structure and are
devoid both, of disulphide bonds and of putative glycosilationAbbreviation: PhyCys, phytocystatins
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doi:10.1016/j.febslet.2007.05.042sites [4]. Most of the PhyCys are small proteins with a molec-
ular mass ranging from 11 to 16 kDa, although some of them
contain a carboxy-terminal extension and have molecular
masses of 23 kDa [5,6]. The function of this C-tail has not
yet been determined.
In the present study, we demonstrate that the carboxy-termi-
nal extensions present in some PhyCys (barley HvCPI-4 and
strawberry FaCPI-1) are able to inhibit in vitro both human
legumain and the legumain-like activity present in barley pro-
tein extracts.2. Materials and methods
2.1. Cystatin sequence comparisons and bioinformatics analyses
Analysis of DNA and comparisons of deduced protein sequences
were done with the current bioinformatics tools. Alignments of amino
acid sequences were performed at the DNA Data Bank of Japan
(http://www.ddbj.nlg.ac.jp) using the CLUSTALW program [7] with
default parameters. The three-dimensional structure of the carboxy
terminal amino acid sequence of HvCPI-4 was modelled by the auto-
mated SWISS-MODEL program [8,9]. The known crystal structure
of the human cystatin C (PDB identiﬁer 1G96) was used to construct
the homology-based model. Structure analysis was performed using
RasMol 2.7 program [10].
2.2. Expression and puriﬁcation of recombinant cystatins from
Escherichia coli
The constructs for barley HvCPI-1–6 [11] and strawberry FaCPI-1
[6] protein expression were introduced in E. coli BL21 CodonPlus
(Stratagene). Bacterial cells containing the recombinant plasmids were
grown at 37 C to an OD550 of ca. 0.5 and induced with 1 mM IPTG
(isopropyl b-D-thiogalactopyranoside) for 2 h, harvested and pro-
cessed. The fusion proteins with a histidine tail were puriﬁed using a
His-Bind Resin (Novagen) following the manufacturer’s instructions,
and puriﬁcation checked by SDS–PAGE.
Two point mutants of the barley cystatin Icy4 cDNA devoid of the
signal peptide sequences were obtained using site-directed mutagenesis
by a recombinant PCR approach as described in [12]. P1 and P2 were
used as external primers and P3–P6 as overlapping internal prim-
ers, which contained the base substitutions (in bold): P1: 5 0-
gatggtaccatcggaaccatggctagc-30; P2: 5 0-tcaaagctttcactggctgctagattc-3 0;
P3: 5 0-gagccgacggtggcc-3 0; P4: 5 0-ggccaccgtcggctc-3 0; P5: 5 0-gaga-
ggtcgaagtcc-3 0; P6: 5 0-ggacttcgacctctc-3 0. The nucleotide changes intro-
duced, which were checked by DNA sequencing, produced the
following amino acid alterations in the wild type HvCPI-4 protein:
Q86ﬁ P and N177ﬁ K (Table 1). In addition, eight truncated variants
were generated by PCR using the following primers and DNA tem-
plates. The Nterm-DA142 and Nterm-DA142 (Q86ﬁ P) variants (P1
and P7: 5 0-gacggtaccacctccttcaccatc-3 0 primers), and the Nterm-
DL150 and Nterm-DL150 (Q86ﬁ P) variants (P1 and P8: 5 0-gacgg-
taccggcgccaagagaggg-30 primers) were made using as DNA template
the Icy4 wild type cDNA and the Q86ﬁ P point mutant. The DT143-
Cterm and DT143-Cterm (N177ﬁ K) variants (P9: 5 0-gacaagcttt-
caggcgtccccggtgtg-3 0 and P2 primers), and the DG151-Cterm andblished by Elsevier B.V. All rights reserved.
Table 1
Schematic amino acid sequences of the HvCPI-4 cystatin and its protein variants
The grey square shows the papain-like inhibitory site. The square indicating the putative legumain-like inhibitory site is scratched.
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gatggtg-30 and P2 primers) were made using the Icy4 wild type cDNA
and the N177ﬁ K point mutant as templates. All the resultant barley
cystatin variants (Table 1) were digested with KpnI and HindIII
(underlined) and inserted in frame into the fusion vector pRSETB
(Invitrogen). Then, the recombinant proteins were puriﬁed to homoge-
neity as described above. Their electrophoretic mobilities in sodium
dodecyl sulphate (SDS) polyacrylamide gel electrophoresis were con-
sistent with the changes introduced (data not shown).
2.3. Cysteine-proteinase inhibitory activity
Inhibitory activity of the recombinant proteins puriﬁed from E. coli
was tested against commercial papain (Sigma; EC 3.4.22.2) as de-
scribed in [13] using BANA (N-benzoyl-DL-arginine-b-naphthylamide)
as substrate. Inhibitory activity against commercial human legumain
(R&D Systems; EC 3.4.22.34) was tested using Z-A-A-N-AMC (N-
carbobenzoxyloxy-Ala-Ala-Asn-7-amido-4-methylcoumarin) as sub-
strate. Brieﬂy, the inhibitor at a concentration of 1 lM was incubated
with 25 ng of proteinase for 10 min at room temperature in a buﬀer
containing 50 mM sodium phosphate pH 6.0, 150 mM NaCl, 2 mM
EDTA and 1 mM DTT. Then, the substrate at a concentration of
25 lM was added and the reactions incubated for 1 h 30 min at
30 C. Protein concentrations were quantiﬁed by the BioRad kit, with
bovine serum albumin (BSA) as standard and the Ki values were deter-
mined from Dixon plots (1/V versus [I]).
2.4. Inhibitory activity of cystatins against barley protein extracts
For inhibitory proteinase assays, seeds of barley (Hordeum vulgare)
cv. Bomi were germinated at 22 C in the dark for 7 days, and used to
collect samples of roots. Developing endosperms of 18 days after ﬂow-
ering were prepared from kernels of plants grown in a greenhouse at
18 C under an 18/6 day/night photoperiod. All samples were frozen
into liquid N2 and stored at 70 C until used for protein extraction.
Samples were ground with mortar and pestle and resuspended in
0.15 M NaCl, 50 mM sodium phosphate pH 6.0, 2 mM EDTA for
1 h at 4 C. After centrifugation for 15 min at 10000 rpm, supernatants
were recovered and their protein content quantiﬁed. Inhibitory activity
of recombinant cystatins was tested in vitro against protein extracts
using Z-A-A-N-AMC as substrate, as described above. Diﬀerent con-
centrations of the inhibitor (0 nM, 25 nM, 50 nM, 100 nM, 200 nM,
and 500 nM) were incubated with 10 lg of a soluble endosperm protein
extract or 5 lg of a soluble root protein extract, at 25 C for 10 min
prior to addition of substrate. Results were expressed as a percentage
of proteinase activity relative to that in the absence of the inhibitor,
and the inhibitory cystatin doses for 50% proteinase activity inhibition
(ID50) for each cystatin was calculated. All assays were carried out in
triplicate.3. Results
3.1. Comparison of the C-terminal tails from carboxy terminal
extended PhyCys
In order to evaluate the similarities in the C-terminal tails of
PhyCys with a carboxy terminal domain, an alignment of the
amino acid sequences of ﬁfteen carboxy terminal extensions
from PhyCys found in the databanks was performed
(Fig. 1). A survey of the alignment indicates strong amino acid
conservation in the compared sequences that suggest a con-
served role in the plant. Interestingly, the amino acid motif
SNSL was detected in all sequences, and this motif resembles
the sequence involved in the inhibition of legumains by human
cystatins.
To test the amino acid similarities between the C-terminal
tails and the human cystatins, an alignment between the amino
acid sequence of the carboxy terminal tail of HvCPI-4 and the
amino acid mature sequence of the strongest human legumain
inhibitor, the cystatin E/M, was done (Fig. 2). Strong amino
acid conservation was observed at the N-terminal region of
the molecules, where the domain involved in legumain inhibi-
tion by human cystatins is located. The three-dimensional
structure of the C-terminal tail of HvCPI-4 was modelled using
as template the known dimeric structure of cystatin C [14],
which is also able to inhibit legumain. Only the N-terminal
part of HvCPI-4 was predicted. A similar structure containing
the a-helix was observed in the region surrounding the back-
side loop (BSL), where the asparagine responsible of legumain
inhibition by human cystatins is located (Fig. 2). All these re-
sults suggested that the C-terminal tails of the carboxy termi-
nal extended PhyCys could be plant inhibitors for legumain
proteinases.
3.2. Diﬀerential cysteine proteinase inhibition of the
phytocystatins
To prove the role of the carboxy terminal extensions of Phy-
Cys as legumain inhibitors, the inhibitory properties of two C-
terminal extended PhyCys, HvCPI-4 and FaCPI-1 and ﬁve not
C-terminal extended barley PhyCys with papain inhibitory
Fig. 1. Alignment of the C-terminal domain present in 15 PhyCys. A schematic representation of an entire cystatin showing the putative functional
motifs is attached. The conserved amino acids are indicated by an asterisk and strong and weak conservative changes are marked with colons and
dots, respectively. A square marks the conserved SNSL motif. GenBank Accession Numbers corresponding to the sequences are as follows:
Amarantus hypochondriacus AhCPI (DQ792503); Arabidopsis thaliana1 AtCYS-6 (NM180239); Arabidopsis thaliana2 AtCYS-7 (NM120593);
Brassica campestris BCPI-1(L41355); Brassica oleracea BoCPI-1 (AY065838); Fragariaxananassa FaCPI-1 (AJ845186); Glycine max (D31700);
Hordeum vulgare HvCPI-4 (AJ748344); Ipomoea batatas CYSPI (AF241536); Malusxdomestica (AY173139); Oryza sativa OC-XII (AK119511);
Ricinus communis (Z49697); Sesamum indicum (AF240007); Triticum aestivum TaMDC1 (AB223039); Zea mays ZmCC4 (AM055633).
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PhyCys were able to inhibit papain, only the two C-terminal
extended PhyCys competitively inhibited in vitro the protein-
ase activity of human legumain (Table 2) using Z-A-A-N-
AMC as substrate. To test if the carboxy terminal region,
and speciﬁcally, if the SNSL motif was involved in this inhibi-
tion, several variants of the HvCPI-4 barley cystatin were con-
structed (Table 1). The variants were expressed in E. coli as
fusion proteins, puriﬁed and assayed against papain and legu-
main (Table 2). The Ki values against both enzymes were deter-
mined. The variants that conserved the ﬁrst part of the protein,
in which the structure that supports a papain-like inhibitory
activity is located, were able to inhibit papain with the excep-
tion of the variants in which the glutamine of the reactive cen-
ter (QTVAG) was changed to a proline residue. Likewise, all
the variants that share the second part of the protein, in which
the putative legumain-like inhibitory motif (SNSL) is located,
presented inhibitory activity against human legumain. When
the asparagine of this motif was changed to a lysine, the vari-
ant lacked its legumain-like inhibitory properties. Similar legu-main inhibition was found when the HvCPI-4 DG151-Cterm
variant, a truncated construction that lacks the eight ﬁrst ami-
no acids of the C-tail, was tested.
To study if PhyCys were able to inhibit the endogenous bar-
ley legumains, in vitro assays against the legumain activity
present in barley extracts were performed with the barley cyst-
atins, the strawberry cystatin, and all the HvCPI-4 variants.
The assays were carried out by adding increasing concentra-
tions of each cystatin to the soluble extract proteins, and the
inhibitory activity was measured by the inhibition of legu-
main-like proteinase activity. As expected, the cystatins able
to inhibit human legumain also inhibit the barley legumain-
like proteinase activities in both developing endosperms and
roots. The inhibitory doses for 50% proteinase activity inhibi-
tion were higher for root legumain activity than for endosperm
one. The endogenous barley legumain-like activities were
inhibited by iodoacetamide, and not inhibited by the non-legu-
main inhibitors leupeptin and E64, which corroborates that
these activities were performed by legumain-like enzymes (data
not shown). As expected, no proteinase inhibition was ob-
Fig. 2. (a) Amino acid alignment of the C-terminal domain of the barley HvCPI-4 cystatin and the mature human E/M cystatin (GenBank Number
NM001323). The putative location of the secondary structures (a-helix and b-sheets) is included. The conserved amino acids are indicated by an
asterisk and strong and weak conservative changes are marked by colons and dots, respectively. A square marks the conserved SNSLmotif. (b) Ribbon
plot of the region surrounding the backside loop of the human cystatin C and the predicted carboxy terminal extension of the barley cystatin HvCPI-4.
The three-dimensional structure of barley cystatin was predicted using the automated SWISS-MODEL program with the human cystatin C as a
template. Figure prepared with RasMol 2.7. The backside loop (BSL) and the asparagine present in the legumain-like inhibitory motif are indicated.
Table 2
Inhibition constant (Ki) values of the six barley cystatins (HvCPI-1–6), the HvCPI-4 variants, and the strawberry FaCPI-1 protein against papain and
legumain; and inhibition of the legumain-like activities in protein extracts from barley tissues
Cystatins Ki (M) ID50 (lM)
Papain Legumain Developing endosperm Root
HvCPI-1 2.0 · 108 nia ni ni
HvCPI-2 5.1 · 108 ni ni ni
HvCPI-3 4.0 · 108 ni ni ni
HvCPI-4 2.2 · 107 1.9 · 107 38 120
HvCPI-5 6.3 · 108 ni ni ni
HvCPI-6 1.7 · 109 ni ni ni
HvCPI-4 Q86ﬁ P ni 1.3 · 107 33 110
HvCPI-4 N177ﬁ K 2.6 · 108 ni ni ni
HvCPI-4 Nterm-DA142 5.6 · 108 ni ni ni
HvCPI-4 Nterm-DA142(Q86ﬁ P) ni ni ni ni
HvCPI-4 Nterm-DL150 1.7 · 107 ni ni ni
HvCPI-4 Nterm-DL150(Q86ﬁ P) ni ni ni ni
HvCPI-4 DT143-Cterm ni 1.9 · 107 18 68
HvCPI-4 DT143-Cterm(N177ﬁ K) ni ni ni ni
HvCPI-4 DG151-Cterm ni 2.9 · 107 22 91
HvCPI-4 DG151-Cterm(N177ﬁ K) ni ni ni ni
FaCPI-1 1.9 · 109 7.6 · 107 20 200
ani indicated no inhibitory activity observed at a 5 lM concentration of the inhibitor.
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the expression vector without insert used as a negative control
(data not shown).4. Discussion
Legumain is the name that Kembhavi et al. [15] gave to an
endopeptidase present in the moth bean that is selective for
the cleavage of asparaginyl bonds. From this study, a common
inhibition by iodoacetamide and the lack of inhibition by E64
and leupeptin for legumain-like proteins stated that they are a
novel group of cysteine proteinases apart of the papain-like
family. Cystatins are potent inhibitors of the papain-like family
of cysteine proteinases. However, inhibitory assays using chick-en egg cystatin demonstrated that both plant and animal legu-
main-like proteins are susceptible to cystatin inhibition
[1,15,16]. Since the protein fold of the legumain family members
seems to be much more closely related to the caspases and
gingipain than to papain [17], Alvarez-Fernandez et al. [18] sug-
gested that the inhibitory sites against papain and legumain-like
cysteine proteinases are far located in the tridimensional struc-
ture of cystatins. Besides, in a comparative study of the legu-
main inhibitory properties of eight human proteins belonging
to the cystatin superfamily, they found that only three of the
type 2 cystatins (cystatins C, E/M and F) were able to inhibit
pig legumain [18]. These proteins share a NS or ND motif
located in the loop between the a-helix and the second b-strand.
The presence of a lysine between the asparagine and the aspartic
acid probably impedes legumain inhibition by cystatin D [19].
2918 M. Martinez et al. / FEBS Letters 581 (2007) 2914–2918In plants, legumains or VPE (vacuolar processing enzymes)
catalyze an Asn- and Asp-speciﬁc limited proteolysis. They
have been involved in several processes. During germination,
legumains act as processing enzymes, and contribute to the
activation of papain-like cysteine proteinases to degrade stor-
age proteins [20–22]. A role in defense against pathogens exe-
cuting programmed cell death due to the caspase activity
observed for several legumains have also been proposed
[23,24]. In spite of these important functions, a plant protein-
aceous legumain inhibitor had not been described. The analy-
sis of the amino acid sequences of the carboxy terminal
extended PhyCys revealed the presence of a common motif
SNSL in a predicted three-dimensional structure similar to
the backside loop of cystatins. This motif shared the NS amino
acids located in the legumain inhibitory backside loop of the
human E/M cystatin, and was not found in the backside loop
of the papain-like inhibitory domain of barley cystatins. The
inhibitory capacity against human legumain of the carboxy
terminal extension of several PhyCys was conﬁrmed, and the
importance of the Asn residue of the SNSL motif determined
by its change to a Lys residue. Likewise, the inhibition of the
legumain-like activity observed in protein extracts from barley
roots and developing endosperms conﬁrms that the carboxy
terminal extensions of these cystatins may act in vivo as endog-
enous regulators of the legumain activity.
In conclusion, we have determined the ﬁrst proteinaceous
legumain-like proteinase inhibitor from plants. Interestingly,
the comparison of the inhibitory features between animal and
plant legumain-like cystatin inhibitors shows a diﬀerent evolu-
tion. In animals, the papain and legumain-like inhibitory motifs
are present in the same amino acid cystatin domain. In plants, a
second domain, probably derived from a duplication of an
ancestral cystatin, retained the legumain-like inhibitory proper-
ties, which were lacked by the papain-like inhibitory domain.
In addition, the fact that carboxy terminal extended PhyCys
act as bifunctional proteinase inhibitors simultaneously inhib-
iting two kinds of proteases makes them good candidates to be
used as transgenes against agronomically important pests and
pathogens.
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